Cortizone-10

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cortizone-10

Cortizone-10 is a specific over-the-counter (OTC) drug entity defined by its composition: a topical formulation containing the low-potency corticosteroid Hydrocortisone. Its function is to provide targeted, temporary relief from minor skin irritation and localized itching.

Property Description
Active Ingredient Hydrocortisone (or Hydrocortisone Acetate)
Form Cream, Ointment, Lotion (Topical formulations)
Pharmacological Class Corticosteroid / Glucocorticoid
Common Use Relief from localized itching and minor skin inflammation
Origin Synthetic (derivative of natural cortisol)

The Identity and Classification of Cortizone-10

This product is categorized pharmacologically as a glucocorticoid, a member of the broader class of corticosteroids used to alleviate inflammatory and allergic skin manifestations. Glucocorticoids are recognized for their effectiveness in suppressing local immune responses. Its designation as an OTC preparation allows for self-management of minor, superficial dermatologic distress without a prescription. Unlike systemic steroid formulations, this product is exclusively intended for dermal application, maintaining a localized effect. The formulation is clinically recognized for its ability to suppress inflammation and is a standard agent used to reduce symptoms associated with dermatitis.

Active Composition: Hydrocortisone and Origin

The single active ingredient is Hydrocortisone, often presented as Hydrocortisone Acetate, which is a synthetic compound. Hydrocortisone is the pharmaceutical equivalent of Cortisol, the naturally occurring glucocorticoid hormone. The product is therefore a monoproduct whose primary therapeutic effects are derived solely from this potent anti-inflammatory compound. The compound's action involves the suppression of processes that generate swelling, redness, and pruritus (itching).

Purpose and Available Topical Forms

The general purpose of the medication is to interrupt the itch-scratch cycle, providing relief by simultaneously reducing local inflammation and the sensation of itching. Cortizone-10 is made available in several topical formulations, including Cream, Ointment, and Lotion. These variations utilize an emollient base to ensure effective contact and appropriate delivery of the active ingredient to the skin layers, thereby optimizing the localized benefit against minor irritation.

Regulatory References

  1. Topical Corticosteroids

What side effects are possible with Cortizone-10?

Possible Side Effects and Safety Information

The safety profile for topical Hydrocortisone, the active ingredient in Cortizone-10, is officially defined by regulatory authorities and is organized by the type and frequency of potential effects. Adverse reactions are primarily classified as Skin and Subcutaneous Tissue Disorders, occurring at the application site.

Localized effects such as burning, stinging, and irritation are commonly reported. Other documented dermal reactions include dryness, redness (erythema), and, with prolonged use, structural changes like skin atrophy (thinning) and the appearance of striae (stretch marks).


Serious Adverse Reactions and Systemic Risk

Although Hydrocortisone is a low-potency topical corticosteroid, rare but serious adverse reactions related to systemic absorption are documented. These effects are classified under Endocrine Disorders and include the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and manifestations of Cushing's syndrome. The risk of these systemic effects is officially associated with prolonged use or application over large surface areas or under occlusive dressings, which increases percutaneous absorption.


Population-Specific and Application Constraints

Official labeling specifically notes a greater susceptibility to systemic toxicity in the pediatric population. Children may absorb proportionally larger amounts of the medication, increasing the risk of HPA axis suppression and potential interference with growth. Safety restrictions documented in regulatory texts specify that the product is generally contraindicated for use in the presence of untreated bacterial, fungal, or viral infections, and application methodology influences the overall safety profile.

Overdose and Emergency Response

Overdose and When to Seek Help: Regulatory Information

The official overdose information for topical hydrocortisone focuses on the risks associated with systemic absorption, which is not expected from acute, normal use. Overdose is defined by the effects of chronic, excessive application (large amounts, large areas, or prolonged use).

Documented Systemic Manifestations of Overdose

Classification Manifestation as Listed by Regulators
Endocrine Effects Reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression
Metabolic Effects Hyperglycemia (high blood sugar) and Glucosuria (sugar in the urine)
Clinical Signs Manifestations resembling Cushing's syndrome
Withdrawal Risk Potential for Glucocorticosteroid insufficiency after discontinuing the product

Mandatory Emergency Actions

While acute topical overdose is generally not anticipated to cause life-threatening symptoms, official guidance requires immediate action for all suspected cases or accidental ingestion:

  • Seek emergency medical attention immediately for any suspected overdose.
  • Call the Poison Help line (e.g., 1-800-222-1222 in the U.S.).
  • Contact emergency services (e.g., 911) if the person has collapsed, had a seizure, or has trouble breathing.

Population-Specific Risk: Regulatory documents note that pediatric patients are more susceptible to systemic toxicity (such as HPA axis suppression) due to their higher skin surface-area-to-body-mass ratio.

Therapeutic Uses of Cortizone-10

What Cortizone-10 Treats: Main Uses and Benefits

The utility of Cortizone-10 (topical Hydrocortisone) is centered on providing focused, temporary symptomatic support for minor skin distress. It is commonly used across domains where symptom clusters may interfere with daily comfort. The use of this medication is relevant across domains where short-term symptomatic assistance is needed to address symptoms related to inflammatory or irritative states.

Relief from Localized Itching and Minor Skin Reactions

This topical agent is commonly used to help with conditions involving episodic or fluctuating manifestations, such as pruritus (intense itching), mild eczema and dermatitis, heat rash, and reactions from insect bites or poison ivy. The medication may provide supportive relief when symptoms interfere with routine activities, and it helps ease the overall burden of this sensory discomfort, contributing to improved day-to-day comfort.

In real-world scenarios, it is applied when symptoms arise from external physical or chemical triggers, such as chafing, chapping, and mild reactions to common household items. It is relevant in situations requiring short-term symptomatic support when symptoms become more noticeable.

Quick Fact: Relief for Pruritic and Inflammatory Symptoms
Supports comfort during episodic flare-ups of itching, redness, and minor swelling.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

This information is strictly based on official regulatory labeling for over-the-counter (OTC) hydrocortisone products.

Eligibility Scope

Classification Population/Condition
Allowed OTC Use Adults and children 2 years of age and older (for minor skin irritations and rashes).
Prohibited / Contraindicated Individuals with a known hypersensitivity to any component of the product.

Eligibility Restrictions

Regulatory labeling establishes specific restrictions and conditions where use is not permitted or requires a healthcare professional's consultation:

  • Pediatric Use: The product must not be used in children under 2 years of age unless directed by a doctor.
  • Specific Conditions: The product is not to be used for the treatment of diaper rash (consult a doctor).
  • Application Sites: The product must not be used in the eyes, or applied directly into the rectum using a mechanical device or applicator. Use in the genital area requires a doctor's consultation if a vaginal discharge is present.
  • Pregnancy/Lactation: Individuals who are pregnant or breastfeeding must consult a healthcare professional before use.
  • Restricted Application: Use for external anal and genital itching is restricted to adults; children under 12 years of age must consult a doctor.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Cortizone-10 (topical Hydrocortisone) indicates that no clinically significant interactions are known when the product is used as directed for localized, temporary relief. The potential for drug interactions is dependent upon systemic absorption of hydrocortisone, which typically occurs only with prolonged use, application to large surface areas, or the use of occlusive dressings.


Potential Systemic Interaction Patterns

Interaction Type Interacting Substances and Formal Risk
Pharmacokinetic (Exposure-Altering) Co-administration with Potent CYP 3A4 Inhibitors (e.g., ketoconazole, grapefruit juice) may inhibit metabolism, potentially increasing plasma concentrations of hydrocortisone if absorption is significant.
Pharmacodynamic (Additive Effect) Concomitant use with Potassium-depleting agents (e.g., certain diuretics) may increase the risk of hypokalemia due to an officially documented additive effect.
Formal Restriction Live or live, attenuated vaccines are formally contraindicated if the medicine's use results in an immunosuppressive systemic exposure state.

Population-Specific Notes: Liver failure is officially documented as a condition that predisposes patients to increased systemic effects, thereby potentially heightening the risk of these interactions. No mandatory timing or separation requirements for doses are documented in the regulatory labels for this topical preparation.

Mechanism of Action

Cortizone-10 contains hydrocortisone, which acts as an agonist at the intracellular Glucocorticoid Receptor (GR), a member of the nuclear receptor superfamily. Upon transdermal absorption into target cells, the lipophilic hydrocortisone molecule binds to the cytoplasmic GR, inducing a conformational change in the receptor-ligand complex. This complex then translocates into the nucleus.

In the nucleus, the activated GR homodimer acts as a transcription factor, primarily engaging in two types of genomic modulation:

  1. Transactivation: The complex binds to specific Glucocorticoid Response Elements (GREs) on the DNA, leading to the increased transcription of anti-inflammatory genes, such as those encoding Annexin A1 (Lipocortin 1).
  2. Transrepression: The GR complex physically interacts with and inhibits pro-inflammatory transcription factors, including NF-κB and AP-1, thereby repressing the transcription of genes encoding inflammatory mediators like cytokines, chemokines, and adhesion molecules.

The upregulation of Annexin A1 inhibits Phospholipase A2 (PLA2) activity. PLA2 is an enzyme necessary for releasing arachidonic acid from cell membrane phospholipids, which is the substrate for the synthesis of eicosanoids, including prostanoids and leukotrienes. Furthermore, the molecular pathway involves the repression of Cyclooxygenase-2 (COX-2) expression. Together, these actions suppress the formation of localized chemical mediators, resulting in systemic physiological modulation characterized by reduced cellular infiltration, decreased local vasodilation, and depressed immune cell function.

Dosage and Administration Information

Administration Protocol: Topical Hydrocortisone 1%

The application of Cortizone-10, an over-the-counter (OTC) 1% hydrocortisone product, is governed by explicit usage instructions outlined in regulatory labeling. The fundamental route of administration for this product is topical (external use only), with strict guidance against use in the eyes or any internal application.


Usage Parameter Regulatory Instruction
Dosing Schedule Apply a thin film to the affected area.
Maximum Frequency Not more than 3 to 4 times daily.
Duration Limit Self-treatment must cease if symptoms persist for more than 7 consecutive days.
Age Rule Approved for use in Adults and Children 2 years of age and older. Use in children under 2 requires a doctor's consultation.

The administration process requires specific procedural steps. Prior to application, the affected skin, particularly for external anal or genital use, should be cleansed with mild soap and water, then gently dried. A critical constraint on application is the instruction to not bandage, cover, or wrap the treated area to create an occlusive environment, unless directed by a healthcare provider. This protocol ensures the administration method remains non-occlusive. The overall use pattern is defined as a fixed-maximum, as-needed daily application, maintaining the product’s role as a temporary supportive agent.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cortizone-10

This overview describes the types of research and study findings that exist for the active ingredient in Cortizone-10 (over-the-counter hydrocortisone), focusing on what has been examined and what remains unclear, based on regulatory and scientific documentation.


Evidence for Temporary Relief of Minor Skin Irritation

The evidence regarding OTC hydrocortisone was evaluated in a history of short-term clinical trials, including studies known as Randomized Controlled Trials (RCTs). These trials were used in research examining short-term symptom changes in adults and children (typically those over the age of two) with localized skin discomfort. Research examined outcomes related to physical discomfort, such as the intensity of itching (pruritus), and objective signs like redness (erythema).

Regulatory assessments, which reviewed this collective data, contributed to the regulatory classification (GRASE) for temporary, symptomatic use in these common, minor irritative states. Research exploring short-term symptom changes typically has limited follow-up durations, which is consistent with the product's non-prescription labeling.

Research Supporting Use in Acute Dermatitis and Bites

For conditions characterized by acute or disruptive episodes, such as irritant dermatitis, insect bites, and reactions from poison ivy, research has explored the ingredient's evaluation for use in temporary symptomatic situations. Studies tracked changes in signs of irritation, like acute rash, over defined time intervals. The evidence contributes to the broader understanding of managing the physical discomfort that accompanies these conditions.

Existing research does not include evaluations of severe, widespread, or weeping skin conditions, as these instances fall outside the scope of non-prescription management. Furthermore, there is limited comparative evidence available to judge the ingredient against other non-steroidal OTC options for these acute reactions.

Research Gaps in Long-Term Follow-up and Outcome Durability

The existing evidence base for OTC hydrocortisone is overwhelmingly focused on short-term outcomes and immediate symptom change. Because regulatory approval is for temporary, symptomatic relief, the research does not typically examine long-term sustained response or maintenance of relief. Findings indicate that long-term effects are not fully established, and research provides context about group patterns but not individual predictions about durability of response over extended periods.

Key Studies & References Topical Corticosteroids: NIH MedlinePlus Drug Information (General Class Overview and Mechanism)

Frequently Asked Questions (FAQ)

Common questions about Cortizone-10 (FAQ)

Q: Can Cortizone-10 be used for bug bites and stings?

Official information indicates that topical hydrocortisone is an agent used for the temporary symptomatic relief of irritation and reactions. This includes the discomfort, such as itching, often associated with insect bites and stings.


Q: Can this cream be applied to the face?

Regulatory guidance suggests that applying the product to sensitive areas, such as the face, should be done with caution. Use on these areas is associated with an increased potential for side effects, including structural changes like thinning of the skin, compared to application on less sensitive areas of the body.


Q: Is it safe to use Cortizone-10 every day for a long time?

Regulatory labeling states that self-treatment must cease if symptoms persist for more than 7 consecutive days. Use that is prolonged or extensive may be associated with an increased potential for rare, systemic side effects, such as skin atrophy (thinning) or HPA axis suppression.


Q: Will Cortizone-10 cause my skin to thin if I use it too much?

Official information states that with prolonged or extensive use or application over large surface areas, documented dermal reactions are described as including changes like skin atrophy (thinning) and the appearance of striae (stretch marks). This is why the product is intended only for short-term, temporary relief.


Q: Can I apply a bandage or dressing over Cortizone-10?

The administration protocol instructs users not to cover or wrap the treated area to create an occlusive, or sealed, environment. Occlusive dressings are understood to increase the potential for the active ingredient to be absorbed by the body, which is linked to an elevated potential for systemic side effects.


Q: Can using Cortizone-10 make my skin more sensitive to the sun?

Patient guidance aligned with regulatory information indicates that topical hydrocortisone may cause the treated skin to burn more easily. Official information includes a general warning that exposure to sunlight on the treated area should be avoided when using the product.


Q: What happens if Cortizone-10 gets into my eyes?

The product is strictly for external use only, and application in the eyes is contraindicated. If accidental contact with the eyes occurs, the standard guidance recommends rinsing the area immediately with plenty of cool tap water.


Q: Is there a potential for the body to absorb the active ingredient systemically?

Systemic absorption, meaning the active ingredient entering the bloodstream, is possible, particularly with prolonged use or application to large surface areas. However, absorption from topical application is generally expected to be very low when used as directed.


Q: Can this medication interact with topical antifungal creams?

Official regulatory labels specify that the product is generally contraindicated for use in the presence of untreated fungal infections. Using a corticosteroid on a fungal infection without concurrent appropriate treatment is formally contraindicated, as official information indicates this may allow the infection to spread or worsen.


Q: Is Cortizone-10 used for mild cases of psoriasis?

Official information indicates that the active ingredient, hydrocortisone, is pharmacologically recognized for use in the temporary relief of inflammatory and allergic skin manifestations. This recognition includes symptoms related to mild cases of psoriasis.


Q: Can Cortizone-10 be used on sensitive skin areas?

Some topical formulations of Cortizone-10 are specifically designed to be suitable for sensitive skin. These specific variants are generally free of common irritants such as fragrances, dyes, and parabens, which is intended to minimize the potential for contact allergy or irritation.


Q: What is the main difference between Cortizone-10 and Benadryl cream?

These two products belong to different pharmacological classes. Cortizone-10 contains hydrocortisone, which is a corticosteroid that is described as reducing inflammation. Benadryl cream contains diphenhydramine, which is classified as an antihistamine that is understood to block the body’s natural histamine response.


Q: Can I apply makeup or lotion over Cortizone-10?

The official product instructions generally advise against using other skin products, including cosmetics or lotions, on the affected area without first consulting a healthcare provider. This approach helps prevent potential alteration of the product's intended action or unintentional increase in absorption.


Q: Can using Cortizone-10 affect a drug test?

The active ingredient is a corticosteroid. Due to the very low rate of systemic absorption expected from the recommended topical use of this over-the-counter product, the presence of the active ingredient is not typically a concern for common drug screenings. However, results are dependent on the specific drug panel used.


Q: Can Cortizone-10 be used on open cuts or wounds?

Regulatory warnings indicate that the product is not to be applied to open cuts, broken skin, or wounds. The restriction exists because applying the medication to damaged skin may be associated with increased absorption into the body, which is linked to a higher potential for side effects.


Q: Does Cortizone-10 interact with any common vitamins or supplements?

While no specific interactions are documented in the regulatory label for topical hydrocortisone and most common vitamins or supplements, patient guidance includes informing a healthcare provider of all medicines, herbs, and supplements being used.


Q: Is it normal for the skin to feel slightly warm after applying Cortizone-10?

Commonly reported localized side effects at the application site include mild sensations such as burning, stinging, or irritation. If this sensation becomes severe, painful, or persists for a long period, official guidance describes stopping use and seeking consultation.


Q: Are there different forms of Cortizone-10 like a lotion or ointment?

Official product information confirms that Cortizone-10 is made available in several different topical formulations to allow for effective dermal application. These forms include Cream, Ointment, and Lotion, which utilize different emollient bases.


Q: Is Cortizone-10 intended to treat the root cause or just the symptoms?

Official documentation describes the general purpose of the medication as providing targeted, temporary relief from minor skin irritation and localized itching. It is described as a product that does not address the underlying root cause of a skin condition.


Q: Can I use Cortizone-10 if I have a fungal skin issue like athlete's foot?

Regulatory labels state that the product is generally contraindicated for use in the presence of untreated bacterial, fungal, or viral infections. Official documentation indicates that a corticosteroid may potentially worsen a fungal condition if it is not simultaneously treated with an appropriate antifungal agent, which is why the restriction is in place.


Q: Are there known issues with Cortizone-10 and alcohol consumption?

No specific interaction between topical Cortizone-10 and alcohol consumption is documented in the regulatory label. However, as a standard safety practice, patient guidance includes informing a healthcare provider about any concurrent alcohol consumption as part of a complete medical history.


Q: Are the safety classifications of Cortizone-10 public knowledge?

Yes, the safety profile, classification as an Over-The-Counter (OTC) drug, and official labeling for the active ingredient, hydrocortisone, are publicly available. This information is defined and published by regulatory authorities like the FDA and NIH.

How should Cortizone-10 be stored and disposed of?

Storage and Disposal of Cortizone-10

Cortizone-10 (topical hydrocortisone) must be stored under specific environmental constraints to maintain stability, as dictated by regulatory documentation.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze.
Protection Keep away from excessive heat, moisture, and direct light. Ensure the cap is closed tightly after use.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused medicine must be properly discarded. Consumers should consult a healthcare professional or local waste disposal company for specific instructions. For pressurized spray forms, the container must not be punctured or incinerated.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cortizone-10 found in:

A-Z Index: